Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor × Cefixime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroblastoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor 1 Relapsed Solid Tumors 1 Drug-Related Side Effects and Adverse Reactions 1 Diarrhea 1

Interventions

senaparib 7 pembrolizumab 6 Irinotecan 6 Paclitaxel 5 Docetaxel 5 Cisplatin 5 Capecitabine 5 Fluorouracil 4 Rifampin 3 Midazolam 3 Leucovorin 3 Itraconazole 3 Injections 3 Bevacizumab 3 pertuzumab 2 ontuxizumab 2 atezolizumab 2 Nivolumab 2 Gemcitabine 2 vofatamab 1 tremelimumab 1 trastuzumab duocarmazine 1 talazoparib 1 sotorasib 1 sintilimab 1 saracatinib 1 ridaforolimus 1 regorafenib 1 prexasertib 1 pexidartinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786669 2021-02-10

VITAC

Children's Hospital Medical Center, Cincinnati

Phase 1 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡